| Andrew Taylor Strand, DO | |
|
6149 E Columbia St, Evansville, IN 47715-9134 | |
| (812) 424-2020 | |
| (812) 424-3000 |
| Full Name | Andrew Taylor Strand |
|---|---|
| Gender | Male |
| Speciality | Ophthalmology |
| Experience | 11 Years |
| Location | 6149 E Columbia St, Evansville, Indiana |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1295077402 | NPI | - | NPPES |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Talley Medical-surgical Eye Care Associates Pc | 3779551122 | 9 |
| Talley Medical-surgical Eye Care Associates Pc | 3779551122 | 9 |
| Talley Medical-surgical Eye Care Associates Pc | 3779551122 | 9 |
News Archive
People who received a mild electrical current to a motor control area of the brain were significantly better able to learn and perform a complex motor task than those in control groups.
To meet the growing demand for its services throughout the Asia-Pacific region, Quintiles, the only fully integrated biopharmaceutical services company offering clinical, commercial, consulting and capital solutions worldwide, today announced the official grand opening of its expanded regional headquarters facility in Singapore's Science Park I.
The U.S. Food and Drug Administration (FDA) has approved Risperdal (risperidone) orally disintegrating tablets, an adult antipsychotic drug, for the symptomatic treatment of irritability in autistic children and adolescents.
BioDelivery Sciences International, Inc. announced that the U.S. Food and Drug Administration has approved the company's Supplemental New Drug Application (sNDA) for a manufacturing specification change for BUNAVAIL (buprenorphine and naloxone) buccal film (CIII).
› Verified 6 days ago
| Entity Name | Talley Medical-surgical Eye Care Associates Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1154319143 PECOS PAC ID: 3779551122 Enrollment ID: O20041012001290 |
News Archive
People who received a mild electrical current to a motor control area of the brain were significantly better able to learn and perform a complex motor task than those in control groups.
To meet the growing demand for its services throughout the Asia-Pacific region, Quintiles, the only fully integrated biopharmaceutical services company offering clinical, commercial, consulting and capital solutions worldwide, today announced the official grand opening of its expanded regional headquarters facility in Singapore's Science Park I.
The U.S. Food and Drug Administration (FDA) has approved Risperdal (risperidone) orally disintegrating tablets, an adult antipsychotic drug, for the symptomatic treatment of irritability in autistic children and adolescents.
BioDelivery Sciences International, Inc. announced that the U.S. Food and Drug Administration has approved the company's Supplemental New Drug Application (sNDA) for a manufacturing specification change for BUNAVAIL (buprenorphine and naloxone) buccal film (CIII).
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Andrew Taylor Strand, DO 6149 E Columbia St, Evansville, IN 47715-9134 Ph: (812) 424-2020 | Andrew Taylor Strand, DO 6149 E Columbia St, Evansville, IN 47715-9134 Ph: (812) 424-2020 |
News Archive
People who received a mild electrical current to a motor control area of the brain were significantly better able to learn and perform a complex motor task than those in control groups.
To meet the growing demand for its services throughout the Asia-Pacific region, Quintiles, the only fully integrated biopharmaceutical services company offering clinical, commercial, consulting and capital solutions worldwide, today announced the official grand opening of its expanded regional headquarters facility in Singapore's Science Park I.
The U.S. Food and Drug Administration (FDA) has approved Risperdal (risperidone) orally disintegrating tablets, an adult antipsychotic drug, for the symptomatic treatment of irritability in autistic children and adolescents.
BioDelivery Sciences International, Inc. announced that the U.S. Food and Drug Administration has approved the company's Supplemental New Drug Application (sNDA) for a manufacturing specification change for BUNAVAIL (buprenorphine and naloxone) buccal film (CIII).
› Verified 6 days ago
Dr. William G Carey, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 954 S Kenmore Dr, Evansville, IN 47714 Phone: 812-402-2020 Fax: 812-402-5300 | |
Dr. Michael R Hodges, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1020 W Buena Vista Rd, Evansville, IN 47710 Phone: 812-423-3131 Fax: 812-426-7020 | |
Dr. Sally G Primus, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1449 Kimber Ln Ste 102a, Evansville, IN 47715 Phone: 126-162-0208 Fax: 812-616-1400 | |
Dr. Terry W Talley, MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 201 W Iowa St, Evansville, IN 47710 Phone: 812-424-2020 Fax: 812-424-3000 | |
Dr. Theodore Jere Stransky, MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 350 W Columbia St, Suite 250, Evansville, IN 47710 Phone: 812-423-3161 | |
Dr. Thomas A Brummer, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 6149 E Columbia St, Evansville, IN 47715 Phone: 812-424-2020 Fax: 812-424-3000 |